Literature DB >> 23528336

[Type 2 diabetes complications].

Jean-Louis Schlienger1.   

Abstract

People with type 2 diabetes are at increased risk of many complications, which are mainly due to complex and interconnected mechanisms such as hyperglycemia, insulino-resistance, low-grade inflammation and accelerated atherogenesis. Cardi-cerebrovascular disease are frequently associated to type 2 diabetes and may become life threatening, particularly coronaropathy, stroke and heart failure. Their clinical picture are sometimes atypical and silencious for a long time. Type 2 diabetes must be considered as an independent cardiovascular risk factor. Nephropathy is frequent in type 2 diabetes but has a mixed origin. Now it is the highest cause of end-stage renal disease. Better metabolic and blood pressure control and an improved management of microalbuminuria are able to slowdown the course of the disease. Retinopathy which is paradoxically slightly progressive must however be screened and treated in these rather old patients which are globally at high ophthalmologic risk. Diabetic foot is a severe complication secondary to microangiopathy, microangiopathy and neuropathy. It may be considered as a super-complication of several complications. Its screening must be done on a routine basis. Some cancer may be considered as an emerging complication of type 2 diabetes as well as cognitive decline, sleep apnea syndrome, mood disorders and bone metabolism impairments. Most of the type 2 diabetes complications may be prevented by a strategy combining a systematic screening and multi-interventional therapies.
Copyright © 2013. Published by Elsevier Masson SAS.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23528336     DOI: 10.1016/j.lpm.2013.02.313

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  16 in total

1.  [Diabetes mellitus as a prognostic marker in oropharyngeal and laryngeal squamous cell carcinoma].

Authors:  K Zaoui; J Doll; P Stiebi; P Federspil; P K Plinkert; J Hess
Journal:  HNO       Date:  2016-07       Impact factor: 1.284

2.  A Hybrid Dynamic Wavelet-Based Modeling Method for Blood Glucose Concentration Prediction in Type 1 Diabetes.

Authors:  Mohsen Kharazihai Isfahani; Maryam Zekri; Hamid Reza Marateb; Elham Faghihimani
Journal:  J Med Signals Sens       Date:  2020-07-03

3.  The efficacy and safety of 5 mg/d Vortioxetine compared to placebo for major depressive disorder: A meta-analysis.

Authors:  Jie Fu; Yangmei Chen
Journal:  Psychopharmacology (Berl)       Date:  2014-05-29       Impact factor: 4.530

4.  Antioxidant, α-glucosidase inhibitory activity and sub-chronic toxicity of Derris reticulata extract: its antidiabetic potential.

Authors:  Pakarang Kumkrai; Oratai Weeranantanapan; Nuannoi Chudapongse
Journal:  BMC Complement Altern Med       Date:  2015-02-27       Impact factor: 3.659

Review 5.  Oxidative Stress Genes, Antioxidants and Coronary Artery Disease in Type 2 Diabetes Mellitus.

Authors:  Miha Tibaut; Daniel Petrovič
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2016

6.  Exendin-4 in combination with adipose-derived stem cells promotes angiogenesis and improves diabetic wound healing.

Authors:  Eunhui Seo; Jae Soo Lim; Jin-Bum Jun; Woohyuk Choi; In-Sun Hong; Hee-Sook Jun
Journal:  J Transl Med       Date:  2017-02-15       Impact factor: 5.531

7.  Increased Expression of Meteorin-Like Hormone in Type 2 Diabetes and Obesity and Its Association with Irisin.

Authors:  Irina AlKhairi; Preethi Cherian; Mohamed Abu-Farha; Ashraf Al Madhoun; Rasheeba Nizam; Motasem Melhem; Mohamed Jamal; Suleiman Al-Sabah; Hamad Ali; Jaakko Tuomilehto; Fahd Al-Mulla; Jehad Abubaker
Journal:  Cells       Date:  2019-10-19       Impact factor: 6.600

8.  Significant association of LXRβ (NR1H2) polymorphisms (rs28514894, rs2303044) with type 2 diabetes mellitus and laboratory characteristics.

Authors:  Mohammad Bagher Sadeghi; Alireza Nakhaee; Ramin Saravani; Saman Sargazi
Journal:  J Diabetes Metab Disord       Date:  2021-01-27

Review 9.  Management of Patients with Newly Diagnosed Diabetic Mellitus: Ophthalmologic Outcomes in Intensive versus Conventional Glycemic Control.

Authors:  Pun Yuet Lam; Shing Chuen Chow; Wai Ching Lam; Loraine Lok Wan Chow; Nicholas Siu Kay Fung
Journal:  Clin Ophthalmol       Date:  2021-06-25

10.  Identification of Microbiota Biomarkers With Orthologous Gene Annotation for Type 2 Diabetes.

Authors:  Yu-Hang Zhang; Wei Guo; Tao Zeng; ShiQi Zhang; Lei Chen; Margarita Gamarra; Romany F Mansour; José Escorcia-Gutierrez; Tao Huang; Yu-Dong Cai
Journal:  Front Microbiol       Date:  2021-07-09       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.